110
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6

, , , , , , , , & show all
Pages 39-47 | Published online: 14 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Paul Y Takahashi, Euijung Ryu, James R Cerhan, Suzette J Bielinski & Janet E Olson. (2021) Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]. Pharmacogenomics and Personalized Medicine 14, pages 545-546.
Read now
Paul Y Takahashi, Euijung Ryu, Suzette J Bielinski, Matthew Hathcock, Gregory D Jenkins, James R Cerhan & Janet E Olson. (2021) No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study. Pharmacogenomics and Personalized Medicine 14, pages 229-237.
Read now
Julia Boyle & Christopher J Stock. (2020) CYP2D6 Expression in Veterans Experiencing Opioid Overdose: A Postmortem Review. Pharmacogenomics and Personalized Medicine 13, pages 289-293.
Read now

Articles from other publishers (10)

Loren Saulsberry, Lavisha Singh, Jaclyn Pruitt, Christopher Ward, Dyson T. Wake, Robert D. Gibbons, David O. Meltzer, Peter H. O’Donnell, Wanda Cruz-Knight, Peter J. Hulick, Henry M. Dunnenberger & Sean P. David. (2022) Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System. Journal of Personalized Medicine 12:7, pages 1145.
Crossref
Stephen Szabadi, Zachary Sila, John Dewey, Dustin Rowland, Madhuri Penugonda & Berrin Ergun-Longmire. (2022) A Review of Prader–Willi Syndrome. Endocrines 3:2, pages 329-348.
Crossref
Rustin D. Crutchley & Nicole Keuler. (2022) Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals. Frontiers in Pharmacology 13.
Crossref
Sean P. David, Lavisha Singh, Jaclyn Pruitt, Andrew Hensing, Peter Hulick, David O. Meltzer, Peter H. O’Donnell & Henry M. Dunnenberger. (2021) The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System. Journal of Personalized Medicine 11:12, pages 1242.
Crossref
Gualberto Ruaño, Joseph Tortora, Saskia Robinson, Seth Baker, Theodore Holford, Andrew Winokur & John W. Goethe. (2021) Subanalysis of the CYP-GUIDES Trial: CYP2D6 Functional Stratification and Operational Timeline Selection. Psychiatry Research 297, pages 113571.
Crossref
Janice Forster, Jessica Duis & Merlin G. Butler. (2021) Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome. Genes 12:2, pages 152.
Crossref
I. Rafi, I. Crinson, M. Dawes, D. Rafi, M. Pirmohamed & F. M. Walter. (2020) The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunities. Journal of Community Genetics 11:3, pages 269-277.
Crossref
Gualberto Ruaño, Saskia Robinson, Theodore Holford, Raveen Mehendru, Seth Baker, Joseph Tortora & John W. Goethe. (2020) Results of the CYP-GUIDES randomized controlled trial: Total cohort and primary endpoints. Contemporary Clinical Trials 89, pages 105910.
Crossref
Gualberto Ruaño, Theodore Holford, Richard L. Seip, John W. Goethe & Raveen Mehendru. (2019) Pharmacogenetic clinical decision support for psychiatric hospitalization: Design of the CYP-GUIDES randomized controlled trial. Contemporary Clinical Trials 83, pages 27-36.
Crossref
Lynn R. Webster. 2018. Handbook of Pain and Palliative Care. Handbook of Pain and Palliative Care 435 445 .